Chatham Lodging Trust Reports Strong Q2 Results, 22% AFFO Growth, and Raises Full-Year Guidance
CLDT has more than doubled off its 52-week low of $6.08.
Summary
Chatham Lodging Trust announced strong Q2 2026 financial results, including a 22% increase in Adjusted FFO per share and raised its full-year guidance, signaling positive operational momentum.
Key Events · Earnings and Guidance · CLDT
-
Strong Q2 Financial Performance
Reported a 22% increase in Adjusted FFO per diluted share to $0.48 and a 3% rise in RevPAR to $158, an all-time second-quarter high. Net income to common shareholders grew to $6 million ($0.13 per diluted share) from $3 million in Q2 2025.
-
Raised Full-Year 2026 Guidance
The company raised its full-year 2026 guidance, with total hotel revenue now projected between $312 million and $316 million, a range noted to be above current consensus.
-
Expanded Margins
Gross operating profit (GOP) margins expanded by 50 basis points to 47%, and Hotel EBITDA margins rose by 220 basis points to 41% in the second quarter, driven by aggressive expense management.
-
Ongoing Share Repurchase Program
Repurchased 0.3 million shares in Q2 at an average price of $9.07, bringing total repurchases to 2.5 million shares at an average price of $7.29 under its $25 million plan.
Analysis · CLDT · Real Estate & Construction
Chatham Lodging Trust delivered robust second-quarter results, significantly outperforming prior guidance with a 22% surge in Adjusted FFO per diluted share and a 3% increase in RevPAR. The company also raised its full-year 2026 guidance, with total hotel revenue now projected above current consensus estimates. This strong operational performance, coupled with an active share repurchase program and the commencement of a new hotel development, indicates positive momentum and management's confidence in future growth, especially as the stock trades near its 52-week high.
At the time of this filing, CLDT was trading at $13.50 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $613.9M. The 52-week trading range was $6.08 to $13.88. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.